To say this has been a big year for Summit Therapeutics (NASDAQ: SMMT) would be a huge understatement. The stock has risen ...

We recently compiled a list of the 10 Best QQQ Stocks to Buy According to Analysts. In this article, we are going to take a ...

Devoid of any marketed drug in its portfolio, investors will likely focus on SMMT's pipeline updates when it reports third-quarter results this month.

Bob Duggan, chairman and co-CEO of Summit Therapeutics Inc. SMMT, is capitalizing on a remarkable 689% stock surge to ...

Presentations will summarize new preclinical data from brain-penetrant, pan-mutant B-Raf degrader program and recent clinical ...

On Monday, Summit Therapeutics Inc (SMMT) stock saw a decline, ending the day at $20.5 which represents a decrease of $-0.71 or -3.35% from the prior close of $21.21. The stock opened at $21.16 and ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Summit Therapeutics (SMMT 7.20%) is an exciting stock for many investors as its shares are up by 158% in the last three ...

However, one company wants to challenge Merck's crown jewel: Summit Therapeutics (NASDAQ: SMMT). This California-based biotech is developing a cancer medicine that has produced excellent clinical ...

One of the hottest stocks to own this year has undoubtedly been Summit Therapeutics (NASDAQ: SMMT), and it could very well fall into that category. Even though the promising biotech doesn't have ...

Oncotelic's Cautionary Note on Forward-Looking Statements ...